Denali Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Denali Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Denali Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Denali Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $29M | 2.0M | 14.52 |
| 2025-06-30 | $13M | 951k | 13.99 |
| 2025-03-31 | $11M | 788k | 13.60 |
| 2024-12-31 | $17M | 853k | 20.38 |
| 2024-09-30 | $4.1M | 141k | 29.13 |
| 2024-06-30 | $3.2M | 136k | 23.22 |
| 2024-03-31 | $7.1M | 344k | 20.52 |
| 2023-12-31 | $6.2M | 291k | 21.46 |
| 2023-09-30 | $2.3M | 110k | 20.63 |
| 2023-06-30 | $3.9M | 132k | 29.51 |
| 2023-03-31 | $2.9M | 127k | 23.04 |
| 2022-12-31 | $3.3M | 120k | 27.81 |
| 2022-09-30 | $1.3M | 43k | 30.68 |
| 2022-06-30 | $189k | 6.4k | 29.61 |
| 2022-03-31 | $1.3M | 39k | 32.24 |
| 2021-12-31 | $4.1M | 92k | 44.63 |
| 2021-09-30 | $3.3M | 65k | 50.42 |
| 2021-06-30 | $191k | 2.4k | 78.38 |
| 2021-03-31 | $1.7M | 30k | 57.11 |
| 2020-12-31 | $485k | 5.8k | 83.68 |
| 2020-09-30 | $224k | 6.3k | 35.86 |
| 2020-06-30 | $65k | 2.7k | 24.29 |
| 2020-03-31 | $207k | 12k | 17.53 |
| 2019-12-31 | $41k | 2.3k | 17.86 |
| 2019-09-30 | $73k | 4.7k | 15.33 |
| 2019-06-30 | $89k | 4.3k | 20.85 |
| 2019-03-31 | $93k | 4.0k | 23.25 |
| 2018-12-31 | $1.6M | 79k | 20.69 |
| 2018-09-30 | $196k | 9.1k | 21.59 |
| 2018-06-30 | $139k | 9.0k | 15.39 |
| 2018-03-31 | $215k | 11k | 19.66 |
| 2017-12-31 | $3.0k | 200 | 15.00 |